Linker Information
General Information of This Linker
Linker ID |
LIN0XMAZP
|
|||||
---|---|---|---|---|---|---|
Linker Name |
Clravable-TAMRA-acetal based linker 12
|
|||||
Antibody-Linker Relation |
Cleavable
|
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
HER2-acetal-ADC 12 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 100.00% (Day 30) | Positive HER2 expression (HER2 +++/++) | ||
Method Description |
NOD-SCID mice with heterotopic SKBR-3 tumor xenografts were injected intravenously with either ADC 12 (1.12 mg/kg; group A), PBS 1x (vehicle; group B) or Kadcyla (1.12 mg/kg; group C) and tumor volume was measured every 2-3 days for 30 days.
|
||||
In Vivo Model | SKBR-3 CDX model | ||||
In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 |
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.22 nM
|
Positive HER2 expression (HER2 +++/++) | ||
Method Description |
Cells were incubated with increasing concentrations in tested compounds for 96 h and cell viability was determined by MTS assay.
|
||||
In Vitro Model | Breast adenocarcinoma | SK-BR-3 cells | CVCL_0033 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) | > 100 nM | Negative HER2 expression (HER2-) | ||
Method Description |
Cells were incubated with increasing concentrations in tested compounds for 96 h and cell viability was determined by MTS assay.
|
||||
In Vitro Model | Breast adenocarcinoma | MDA-MB-231 cells | CVCL_0062 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.